0001214659-19-002039.txt : 20190311 0001214659-19-002039.hdr.sgml : 20190311 20190311175314 ACCESSION NUMBER: 0001214659-19-002039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190308 FILED AS OF DATE: 20190311 DATE AS OF CHANGE: 20190311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Durrant Cameron CENTRAL INDEX KEY: 0001421882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 19673324 MAIL ADDRESS: STREET 1: 90, FAIRMOUNT ROAD WEST CITY: CALIFON STATE: NJ ZIP: 07830-3330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-44553.xml PRIMARY DOCUMENT X0306 4 2019-03-08 0001293310 HUMANIGEN, INC HGEN 0001421882 Durrant Cameron C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true true false false Chief Executive Officer Common Stock, $0.001 par value 2019-03-08 4 A false 75000 0.665 A 238583 D Employee Stock Option Exercise (Right to Buy) 0.665 2019-03-08 4 M false 75000 0 D 2018-03-09 2026-09-12 Common Stock 75000 8434771 D These stock options were granted to the executive on March 9, 2018 to preserve the incentive offered to the executive in connection with his stock option granted on September 13, 2016, after giving effect to the dilution resulting from the completion of the Company's previously reported restructuring transaction on February 27, 2018. Accordingly, the option was deemed vested as to one-half of the underlying shares as of the grant date, with the remainder vesting in six quarterly installments commencing June 13, 2018. /s/ Deborah Brown, Attorney-In-Fact 2019-03-11